Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

ClinicalTrials.gov ID: NCT02062060

Public ClinicalTrials.gov record NCT02062060. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 7:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation

Study identification

NCT ID
NCT02062060
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Dr. Reddy's Laboratories Limited
Industry
Enrollment
325 participants

Conditions and interventions

Interventions

  • Abametapir Lotion 0.74% w/w Drug
  • Vehicle Lotion Drug

Drug

Eligibility (public fields only)

Age range
6 Months and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2014
Primary completion
Jun 30, 2014
Completion
Jul 31, 2014
Last update posted
May 11, 2020

2014

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Cactus Kids Pediatrics Yuma Arizona 85364
Axis Clinical Trials Los Angeles California 90017
Radiant Reserach Pinellas Park Florida 33781
Spence Medical Reserach Picayune Mississippi 39466
Haywood Pediatric Clyde North Carolina 28721
LSRN Research Nashville Tennessee 37206
Wee Care Pediatrics Layton Utah 84041

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02062060, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02062060 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →